Horizon Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$366K Buy
2,399
+45
+2% +$6.9K 0.05% 98
2025
Q4
$325K Hold
2,354
0.05% 98
2025
Q3
$302K Hold
2,354
0.04% 97
2025
Q2
$285K Buy
2,354
+66
+3% +$7.44K 0.05% 82
2025
Q1
$255K Sell
2,288
-33
-1% -$3.51K 0.04% 84
2024
Q4
$226K Buy
2,321
+33
+1% +$3.52K 0.04% 83
2024
Q3
$263K Hold
2,288
0.05% 66
2024
Q2
$244K Buy
2,288
+72
+3% +$7.23K 0.06% 60
2024
Q1
$214K Sell
2,216
-79
-3% -$8.1K 0.06% 74
2023
Q4
$232K Buy
2,295
+79
+4% +$7.63K 0.06% 70
2023
Q3
$226K Hold
2,216
0.09% 66
2023
Q2
$224K Buy
2,216
+14
+0.6% +$1.4K 0.09% 70
2023
Q1
$203K Buy
+2,202
New +$192K 0.15% 72

Other funds holding NVS

Horizon Wealth Management's NVS Position: Q1 2026 in Review

Horizon Wealth Management increased its Novartis (NVS) stake by 1.9% in Q1 2026, buying an estimated $6.9K and bringing the position to 2,399 shares worth $366K. The position accounts for 0.05% of the portfolio, ranked #98.

Horizon Wealth Management first reported a position in NVS in Q1 2023 and has held it in 13 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Horizon Wealth Management held 2,399 shares of Novartis worth $366K as of Q1 2026.
  • Horizon Wealth Management bought 45 Novartis shares in Q1 2026, an estimated $6.9K.
  • Novartis made up 0.05% of Horizon Wealth Management's portfolio in Q1 2026, its #98 holding.
  • Horizon Wealth Management first reported a position in Novartis in Q1 2023 and has held it in 13 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Horizon Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.